Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?-Reference-Cited by-同舟云学术

Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?

Published:2019-01-22 Issue:7 Volume:10 Page:696-706
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Gall Tamara M.H.¹,Gerrard Gareth²³,Frampton Adam E.¹,Castellano Leandro¹,Ahmad Raida⁴,Habib Nagy¹,Spalding Duncan¹,Pai Madhava¹,Foroni Letizia⁴,Jiao Long R.¹

Affiliation:

1. Department of Surgery and Cancer, Imperial College, Hammersmith Hospital Campus, London W12 0HS, United Kingdom

2. Faculty of Medicine, Imperial College, Hammersmith Hospital Campus, London W12 0HS, United Kingdom

3. Current address: Sarah Cannon Molecular Diagnostics, HCA Healthcare UK, London WC1E 6JA, United Kingdom

4. Department of Histopathology, Imperial College, Hammersmith Hospital Campus, London W12 0HS, United Kingdom

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlations;Scientific Reports;2024-07-08

2. Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlations;2023-12-06

3. Complex Patterns of Genomic Heterogeneity Identified in 42 Tumor Samples and ctDNA of a Pulmonary Atypical Carcinoid Patient;Cancer Research Communications;2023-01-10

4. KRAS mutation allele frequency threshold alters prognosis in right‐sided resected pancreatic cancer;Journal of Surgical Oncology;2022-03-25

5. Long Non-coding RNA AFAP1-AS1 Facilitates Prostate Cancer Progression by Regulating miR-15b/IGF1R Axis;Current Pharmaceutical Design;2021-11-10